in total, 224 patients were randomized to treatment: 75 to placebo, 75 to the A. paniculata 1,200 m g daily, and 74 to A. paniculata 1,800 m g daily. One patient was incorrectly randomized and was excluded from the efficacy analyses. The baseline disease characteristics were similar in the three groups ( Table 1) . In all, 180 of 224 patients (80.7 % ) completed the 8-week trial